Author Archive

Fierce Biotech

Chutes & Ladders

Eisai's cancer genomics drug discovery subsidiary, H3 Biomedicine, promoted Ping Zhu, Ph.D., to president and chief scientific officer, and Ross… Read More
1 2 3 9